Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough drugs targeted to specific indications and patients.

Contact Information

215 First St
Cambridge, MA 02142
United States

    Overview

    Total FundingEmployeesLast Funding DateStatus
    $52,000,00011-502015-10-15Operating

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2015-10-15$52,000,000VentureThird Rock VenturesGSK (GlaxoSmithKline), SR One